These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5975306)

  • 1. [Symposium on the open negative syndrome. 5. Studies on the open negative syndrome occurring after chemotherapy with secondary antituberculous drugs].
    Kimura Y
    Kekkaku; 1966 Aug; 41(8):383-6. PubMed ID: 5975306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium on the open negative syndrome. 4. Study on the prognosis of the open negative syndrome occurring after chemotherapy with primary anti-tuberculous drugs].
    Fujioka M; Yoshida F; Komoto H; Takahashi O; Nishiyama K
    Kekkaku; 1966 Aug; 41(8):381-3. PubMed ID: 5975305
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents.
    Kimura Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:71-6. PubMed ID: 5298482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symposium on the open negative syndrome. 2. Formation of the open negative cavity during the course of original treatment and the fate of the cavity].
    Miyagi Y
    Kekkaku; 1966 Aug; 41(8):375-8. PubMed ID: 5975303
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study on chemotherapy using so-called tertiary drugs for severe cavitary pulmonary tuberculosis failed to respond to chemotherapy by primary and secondary antituberculous drugs].
    Nagata A; Matsumoto M; Yamamoto M; Nakamura H
    Kekkaku; 1966 Jun; 41(6):207-13. PubMed ID: 4290189
    [No Abstract]   [Full Text] [Related]  

  • 6. "Open-negative" syndrome. Clinical course of its development and subsequent destiny.
    Miyagi Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:54-9. PubMed ID: 5298479
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the prognosis of cases with open negative cavity developing mainly due to therapy with primary antituberculosis drugs.
    Fujioka K; Yoshida F; Kawamoto H; Takahashi O; Nishiyama K; Hidaka O
    Jpn J Tuberc; 1966 Dec; 13():Suppl:65-70. PubMed ID: 5298481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs].
    Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W
    Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Syndrome of "open cavity healing". (Analysis of late results of treatment)].
    Zierski M
    Gruzlica; 1967 Mar; 35(3):219-26. PubMed ID: 6041224
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on pulmonary tuberculous patients failed to respond to chemotherapy using primary antituberculous drugs.
    Ishiguro S
    Kekkaku; 1968 Feb; 43(2):71-83. PubMed ID: 4971167
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up observation on open negative cases].
    Taga M; Yamamoto M; Hirose H; Katayama A; Matsumoto M
    Kekkaku; 1967 Jan; 42(1):9-14. PubMed ID: 6036571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs].
    Kost A
    Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary tuberculosis with cavitation].
    Aoyagi T
    Naika; 1967 Nov; 20(5):908-15. PubMed ID: 5599392
    [No Abstract]   [Full Text] [Related]  

  • 16. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the infectiousness of initially open pulmonary tuberculosis with reference to enforced isolation].
    Breu K
    Med Monatsschr; 1970 May; 24(5):198-201. PubMed ID: 4997660
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of antibacterial treatment of pulmonary tuberculosis in patients with primary resistance to drugs].
    Mysakowska H; Pietroń E; Sikora-Rózyńska M; Smaga M; Litwin B; Rybicka-Stryjecka Z
    Pol Tyg Lek; 1965 May; 20(19):686-8. PubMed ID: 5844021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.